PAS
EW icon

Point72 Asia (Singapore)’s Edwards Lifesciences EW Stock Holding History

Point72 Asia (Singapore)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.72M Buy
47,780
+39,404
+470% +$3.08M 0.58% 40
2025
Q2 		$655K Sell
8,376
-11,221
-57% -$837K 0.12% 166
2025
Q1 		$1.42M Buy
+19,597
New +$1.4M 0.37% 60
2024
Q3 		– Sell
-1,971
Closed -$182K – 1087
2024
Q2 		$182K Buy
+1,971
New +$175K 0.04% 321

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Point72 Asia (Singapore)'s EW Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its Edwards Lifesciences (EW) stake by 470% in Q3 2025, buying an estimated $3.08M and bringing the position to 47,780 shares worth $3.72M. The position accounts for 0.58% of the portfolio, ranked #40.

Point72 Asia (Singapore) first reported a position in EW in Q2 2024 and has held it in 4 quarters since. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Point72 Asia (Singapore) held 47,780 shares of Edwards Lifesciences worth $3.72M as of Q3 2025.
  • Point72 Asia (Singapore) bought 39,404 Edwards Lifesciences shares in Q3 2025, an estimated $3.08M.
  • Edwards Lifesciences made up 0.58% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #40 holding.
  • Point72 Asia (Singapore) first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 4 quarters since.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.